Bicyclic Compound Stimulates Skin Collagen and Elastin

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current cosmetic and therapeutic approaches fail to effectively stimulate and restore collagen and elastin levels in the skin, leading to aging issues such as wrinkles and hair loss, with existing products often being ineffective or causing unhealthy side effects.

Innovation Solution

A topical composition containing a stable bicyclic compound, 3,6,6-trimethyl-5-(propan-2-yl)bicyclo[3.1.1]hepta-1,3-diene, which stimulates natural collagen and elastin production, increasing their levels in the skin, hair, and nails, and is designed to repair skin damage including burns.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Shape

If animal collagen is injected into the skin to plump wrinkles and add volume, then skin appearance is improved, but unhealthy side effects occur

Engineering Contradiction:
Improveskin appearanceVSAvoidunhealthy side effects
Core Design Contradiction:
ShapeVSObject-affected harmful factors

Solution Approach 1:

The invention stimulates the skin's own fibroblasts to produce collagen and elastin endogenously using a bicyclic compound topically applied to the skin. This self-service approach eliminates the need for external animal collagen injections, thereby avoiding the unhealthy side effects while still achieving skin plumping and wrinkle reduction through natural collagen production.

Inventive Principle:
Principle #25Self-service

2Strength

If elastin protein from cows or birds is used in skin care products, then skin elasticity is theoretically improved, but the protein does not penetrate the skin layer and forms only a coating

Engineering Contradiction:
Improveskin elasticityVSAvoidpenetration effectiveness
Core Design Contradiction:
StrengthVSReliability

Solution Approach 1:

Instead of relying on external elastin proteins that cannot penetrate the skin, the invention activates the skin's own fibroblasts to produce elastin endogenously. The bicyclic compound penetrates the skin layer and stimulates natural elastin synthesis, ensuring reliable delivery of elastin to where it is needed within the skin structure rather than forming a superficial coating.

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The bicyclic compound acts as an intermediary that penetrates the skin layer and mediates the stimulation of fibroblasts to produce elastin. This intermediary approach overcomes the penetration barrier that prevents direct application of animal-derived elastin proteins, enabling effective elastin delivery through biological activation rather than physical deposition.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Quantity of substance

If previous attempts are made to stimulate collagen production, then collagen levels may be slightly increased, but the effects are minor or fail to produce significant results

Engineering Contradiction:
Improvecollagen levelsVSAvoidstimulation effectiveness
Core Design Contradiction:
Quantity of substanceVSProductivity

Solution Approach 1:

The invention uses a specific bicyclic compound with a unique molecular structure that has proven to be highly effective in stimulating fibroblast activity and collagen production. This represents a parameter change in the chemical structure of the active ingredient, moving from conventional stimulants to this specific bicyclic framework, which produces significantly enhanced collagen synthesis compared to previous attempts.

Inventive Principle:
Principle #35Parameter changes

Data Source

PatentEP3044195B1Collagen and elastin stimulating compound and topical compositions comprising such compound
Publication Date: 2021.02.17 JOVENTIS
  • EP3044195B1 patent drawingFigure 1~2
  • EP3044195B1 patent drawingFigure 3~4
  • EP3044195B1 patent drawingFigure 5~6

AI summary

The present invention relates to a bicyclic compound of Formula (I) and to a composition for a cosmetic and therapeutic use and to a composition comprising an acceptable vehicle and an effective amount of the compound of Formula (I).